Jun 15,2017

Roundup: More ADA news from Medtronic, Care4Life, Hygieia, and iSage

Late last week we did a pre-conference roundup of news from the 77th Scientific Sessions of the American Diabetes Association. Now that the show has concluded, here’s a few more notable stories from Care4Life, Medtronic, and Hygieia.

CLINICAL STUDY

#mobile app

View Analyst & Ambassador Comments
Go to original news
Jun 16,2017

JAMA study: technology to self-monitor blood glucose levels no better than traditional management of type 2 diabetes

Diabetes management is among the most active, well-funded and rapidly-evolving areas of digital health. Connected tools that allow people living with diabetes to monitor their own blood glucose levels and work with digital coaching platforms to choose the best lifestyle practices to stay healthy abound, as do analytics platforms that enable remote monitoring and more detail-rich data visualization to help clinicians keep better tabs on their patients. But compared with the traditional method of in-office visits, does self-monitoring of blood glucose (SMBG) via digital tools result in better health and wellness for people with non-insulin-treated type 2 diabetes?

CLINICAL STUDY

#bgm

View Analyst & Ambassador Comments
Go to original news
Jun 29,2017

Insulin delivery, workout routes, and more added to Apple HealthKit

Apple has upgraded its HealthKit app framework to provide more tracking options for people with diabetes. Insulin delivery is a big addition and one that shows that Apple is interested in being involved in “closed loop” diabetes interventions that include both glucose tracking and insulin dosing. HealthKit will track both basal and bolus insulin in units. Dexcom will take advantage of the Apple Watch’s native Bluetooth to allow users of Dexcom’s CGM to access their blood glucose data directly from the Watch, even if they’ve left their phone at home.

PRODUCT

#cgm

#closed loop

View Analyst & Ambassador Comments
Go to original news
Jun 05,2017

Insulet Corporation to Present at Upcoming Investor Conference

Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its Omnipod® Insulin Management System, today announced that management will present at the William Blair & Co. 37th Annual Growth Stock Conference in Chicago, Illinois on Tuesday, June 13, 2017 at 12:50 p.m. (Central Time).

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Jun 05,2017

DarioHealth Launching New Social Initiative at ADA's 77th Scientific Sessions

DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, today announced that it is launching a new social initiative called DarioCares™ at the American Diabetes Association's (ADA) 77th Scientific Sessions in San Diego later this week. The aim of DarioCares™ is to leverage company's compelling offerings and to raise funds for charitable and non-profit organizations working in the field of diabetes. DarioHealth will donate a portion of the proceeds of every sale made from this channel to organizations that will participate in our DarioCares™ plan.

View Analyst & Ambassador Comments
Go to original news
Jun 07,2017

Dexcom Announces FDA Approval of G5 Mobile App for Android Devices

Dexcom is pleased to announce the Food and Drug Administration (FDA) approval of the Dexcom G5 mobile app for Android devices. Beginning in June, Android users will have access to the free app for the Dexcom G5 Mobile CGM System, allowing people with diabetes to view and monitor their glucose levels on their mobile devices to manage their diabetes in real time. The Dexcom G5 Mobile CGM System is the first and only CGM platform available for Android in the United States, complementing the 2015 iOS launch.

REGULATORY FDA

#cgm

#mobile app

View Analyst & Ambassador Comments
Go to original news
Jun 07,2017

Medtronic Initiates U.S. Launch of World's First Hybrid Closed Loop System for Type 1 Diabetes

Medtronic plc (NYSE:MDT), today announced the U.S. launch of the MiniMed(TM) 670G system - the world's first Hybrid Closed Loop system for people with type 1 diabetes. The system also exclusively features the CONTOUR®NEXT LINK 2.4 blood glucose monitoring system (BGMS) from Ascensia Diabetes Care.

PRODUCT

#closed loop

#insulin pump

#cgm

View Analyst & Ambassador Comments
Go to original news
Jun 08,2017

ASCENSIA DIABETES CARE ANNOUNCES STRATEGIC ALLIANCE WITH INSULET CORPORATION TO CONNECT CONTOUR®NEXT ONE BGMS AND OMNIPOD DASH™ PDM

Ascensia Diabetes Care today announced it has entered into a strategic alliance by signing a development agreement with Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (the Omnipod System). Under the terms of this agreement, the Ascensia CONTOUR®NEXT ONE blood glucose monitoring system (BGMS) will connect to Insulet's next-generation Omnipod System (the Omnipod Dash™ System), which is currently in development. Seamlessly connecting the CONTOUR®NEXT ONE BGMS and the Omnipod Dash™ System will provide people living with diabetes with an innovative continuous insulin delivery system to manage their diabetes, powered by remarkably accurate blood glucose readings.

COLLABORATION PARTNERSHIP

#connected device

#bgm

#insulin pump

View Analyst & Ambassador Comments
Go to original news
Jun 09,2017

Insulet to Preview New Clinical Data and Next Generation Omnipod® System at the American Diabetes Association's 77th Scientific Sessions

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod System), today announced it will present new data for its Omnipod System including results from a hybrid closed-loop study utilizing the Omnipod Horizon™ Automated Glucose Control System (Omnipod Horizon System) involving a total of 24 pediatric patients from six to 18 years of age at the American Diabetes Association (ADA) 77th Scientific Sessions at the San Diego Convention CenterJune 9-13, 2017.

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Jun 09,2017

One Drop Expands Features and Subscription Programs to Provide More Accessible Care to People with Diabetes Worldwide

One Drop today announced a significant expansion of its accessibility features and educational programming, including integration with Amazon's Alexa voice technology. One Drop's new Alexa interface empowers people with diabetes to track blood glucose, food, and physical activity, and provides voice command access to all their diabetes data.

PRODUCT

#bgm

#coaching

#mobile app

View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES